XML 60 R51.htm IDEA: XBRL DOCUMENT v3.19.3
Net Loss Per Share - Schedule of Diluted Net Loss Per Share (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Numerator        
Net loss attributable to Inovio Pharmaceuticals, Inc. (numerator for use in basic net loss per share) $ (23,090,693) $ (25,015,672) $ (81,697,181) $ (64,005,625)
Adjustment for decrease in fair value of derivative liability and interest expense (2,177,250) 0 0 0
Numerator for use in diluted net loss per share $ (25,267,943) $ (25,015,672) $ (81,697,181) $ (64,005,625)
Denominator        
Weighted average number of common shares outstanding (denominator for use in basic net loss per share) (shares) 99,007,985 92,423,122 98,204,375 91,350,117
Effect of dilutive potential common shares (shares) 3,799,071 0 0 0
Denominator for use in diluted net loss per share (shares) 102,807,056 92,423,122 98,204,375 91,350,117
Net loss per share, diluted (dollars per share) $ (0.25) $ (0.27) $ (0.83) $ (0.70)
Net loss per share, basic (dollars per share) $ (0.23) $ (0.27) $ (0.83) $ (0.70)